PMDAsafety guidance83% confidence
[ANZEN]Revisions of PRECAUTIONS: Donanemab(genetical recombination) , etc.
Source: PMDA
Why This Matters
Why this matters: illustrates how regulators handled a comparable safety guidance decision relevant to VA Medical Centers.
Regulatory Analysis
PMDA regulatory document relevant to this signal.
Supporting Context
- Therapeutic area
- Psychiatry · PTSD
- Sub-indication
- General
Related signal: Study Compares PE Therapy, Pharmacotherapy, and Combination for PTSD in Veterans
Source
FDA document
View source